FDA Approves Tecentriq as Initial Treatment for Advanced NSCLC
News
The U.S. Food and Drug Administration (FDA) has approved Genentech‘s Tecentriq (atezolizumab) as an initial treatment of people with metastatic non-small cell lung ... Read more